ALNOV:EPA
Novacyt SA
0,44 €
arrow_upward
+1,38%(+0,0060) 1 p
18. nov, 17:35:20 GMT +1 · EUR
search
Kõik sümbolid
| Sümbol | Hind | Muutus | % muutus |
|---|
insights_autoÜksuse ALNOV põhistatistika genereerimine…
Ava
0,44 €
Kõrge
0,44 €
Madal
0,43 €
Turu kapit.
32,06 mln
Keskm. maht
139,48 tuh
Maht
150,99 tuh
52 näd kõrgeim
1,04 €
52 näd madalaim
0,29 €
Aktsiatulu
−0,38 €
Käibivad aktsiad
72,59 mln
Töötajate arv
228
Ava
0,44 €
Kõrge
0,44 €
Madal
0,43 €
Turu kapit.
32,06 mln
Keskm. maht
139,48 tuh
Maht
150,99 tuh
52 näd kõrgeim
1,04 €
52 näd madalaim
0,29 €
Aktsiatulu
−0,38 €
Käibivad aktsiad
72,59 mln
Töötajate arv
228
Uudised
Veebiallikatest ja uudistepartneritelt
Yahoo Finance
·
1 tunni eest
Nasdaq, Dow, S&P 500 Futures Climb Ahead Of Anthropic’s Record Debut: SLS, GLD, TTWO, UNH In Focus
Barron's
·
6 tunni eest
Generac Jolted After Nvidia Earnings. Why It’s a Top S&P 500 Stock Today.
The Motley Fool
·
1 tunni eest
The S&P 500 Just Ended a Run of 155 Trading Days Above Its 200-Day Average. Here's What Followed 34 Similar Runs Since 1950.
Hedgeye
·
15 tunni eest
Why Negative Gamma Has Taken the Brakes Off the S&P 500
Profiil
Novacyt Group is an Anglo-French biotechnology group focused on clinical diagnostics, with offices in Camberley, Surrey, United Kingdom and Vélizy-Villacoublay, France. The company produces in vitro and molecular diagnostic tests, supplying assays and reagents worldwide. Its business units include Primerdesign, Microgen Bioproducts and Lab21 Healthcare.
In January 2020 the company announced that its molecular diagnostics division, Primerdesign, had launched a molecular test for the 2019 strain of SARSr-CoV. The test was approved as eligible for procurement under the World Health Organization's Emergency Use Listing process in April 2020, meaning that the test could be supplied by the United Nations and other procurement agencies supporting the COVID-19 response. In the same month Novacyt announced a collaboration with AstraZeneca, GlaxoSmithKline and the University of Cambridge to support the UK in its COVID-19 national screening programme at a new testing laboratory at the university's Anne McLaren laboratory. Wikipedia
Teave üksuse Novacyt SA kohta
TegevjuhtDavid Allmond
Töötajad228
Asutatud3. juuli 2006
Peakontorid-
SektorHealth Care
Valdkond-
Veebisaitnovacyt.com